Skip to content
Inciteful Med

Pathology & Understanding Your Reports

Last updated:

Granulomatosis with polyangiitis (GPA) is diagnosed and monitored using ANCA blood tests, tissue biopsies, and the Birmingham Vasculitis Activity Score (BVAS). Biopsies often show necrotizing granulomatous inflammation, while PR3-ANCA is the most common blood marker for the disease.

Key Takeaways

  • • The ANCA blood test, particularly the PR3-ANCA marker, is widely used to help diagnose and monitor Granulomatosis with polyangiitis (GPA).
  • • A negative ANCA test does not rule out GPA, as 10-20% of patients with limited disease may test negative.
  • • A tissue biopsy is the gold standard for confirming GPA, with pathologists specifically looking for necrotizing granulomatous inflammation.
  • • The Birmingham Vasculitis Activity Score (BVAS) measures current, treatable inflammation, with a score of zero indicating disease remission.

Medical reports can feel like they are written in a different language. When you are diagnosed with Granulomatosis with polyangiitis (GPA), you will likely see results from blood tests, urine samples, and tissue biopsies [1][2]. Understanding a few key terms can help you “decode” these reports and have more meaningful conversations with your medical team.

Decoding the ANCA Test

The ANCA test (Anti-Neutrophil Cytoplasmic Antibody) is a blood test used to help diagnose and monitor GPA [3][4].

  • PR3-ANCA (or c-ANCA): This is the most common “marker” for GPA [5][6].
  • MPO-ANCA (or p-ANCA): This is more common in other types of vasculitis, though it is sometimes seen in GPA [5][7].
  • ANCA-Negative: About 10–20% of people with GPA—especially those with limited disease (disease confined to the nose, ears, or lungs)—may have a negative ANCA test [8][5]. In these cases, doctors rely more heavily on biopsies and imaging to make the diagnosis [1][9].

Understanding Your Biopsy Report

A biopsy is the “gold standard” for confirming GPA [1][2]. Pathologists look for specific microscopic signs of the disease:

  • Necrotizing Granulomatous Inflammation: This is the hallmark of GPA [10][11]. “Necrotizing” means tissue death, and “granulomatous” refers to the specific ball-like clusters of immune cells (granulomas) that form as a result of inflammation [10][12].
  • Pauci-Immune Glomerulonephritis: If you have a kidney biopsy, you will likely see this term. “Pauci-immune” means that when doctors look at the kidney under a special fluorescent light, they see very few immune deposits [13][1]. This is a key way doctors distinguish GPA from other kidney diseases like Lupus [13].
  • Crescents: This describes a specific shape of inflammation inside the filtering units of the kidney [13][1]. Seeing “crescents” on a report usually means the kidney inflammation is active and needs urgent treatment [13][14].

The BVAS: Your “Activity Score”

The Birmingham Vasculitis Activity Score (BVAS) is a tool doctors use to measure how active your GPA is at any given time [15][16].

  • How it works: Your doctor goes through a checklist of symptoms across different organ systems (skin, eyes, lungs, kidneys, etc.) [15][16].
  • What the numbers mean: A higher score means more active disease [15]. A score of zero means you have reached remission—the primary goal of treatment [17][18].
  • Activity vs. Damage: It is important to know that BVAS measures active inflammation that can be treated [15]. It is different from the Vasculitis Damage Index (VDI), which tracks permanent scarring or damage that occurred in the past and cannot be reversed by medication [15][16].

Common Jargon Found in Reports

Term Plain Language Explanation
Active Sediment Blood or protein found in a urine sample, which can be a sign of active kidney inflammation [13].
Glomerular Sclerosis Permanent scarring in the kidney’s filters [19].
Giant Cells Large immune cells often found inside granulomas [10][11].
Vasculitis of Small Vessels Inflammation specifically affecting the smallest blood vessels, like capillaries [10][12].
Subglottic Stenosis Narrowing of the windpipe below the vocal cords [20].

Frequently Asked Questions

What does PR3-ANCA mean on my blood test?
PR3-ANCA, also known as c-ANCA, is the most common antibody marker found in the blood of people with Granulomatosis with polyangiitis (GPA). Its presence helps doctors diagnose the condition and monitor disease activity over time.
Can I still have GPA if my ANCA test is negative?
Yes, about 10-20% of people with GPA have a negative ANCA test, especially if the disease is limited to the nose, ears, or lungs. In these cases, doctors rely more heavily on biopsies and imaging to confirm the diagnosis.
What does necrotizing granulomatous inflammation mean on a biopsy?
This is the hallmark microscopic sign of GPA. 'Necrotizing' refers to tissue damage, while 'granulomatous' means there are ball-like clusters of immune cells causing the inflammation.
What is the Birmingham Vasculitis Activity Score (BVAS)?
The BVAS is a tool doctors use to measure how active your GPA is across different organ systems. A higher score indicates more active inflammation, while a score of zero means you have reached remission.
What does it mean if my kidney biopsy shows crescents?
Crescents describe a specific shape of inflammation inside the filtering units of the kidneys. Seeing crescents on a pathology report usually means the kidney inflammation is highly active and requires urgent treatment.

Questions for Your Doctor

  • • Based on my kidney biopsy, which category of the Berden classification do I fall into (Focal, Crescentic, Mixed, or Sclerotic)?
  • • What is my current Birmingham Vasculitis Activity Score (BVAS), and how will we track this to know if I'm in remission?
  • • If my ANCA test was negative, how did we confirm my diagnosis? Was it through a biopsy or imaging?
  • • Do my biopsy results show any signs of 'global sclerosis' or permanent scarring?
  • • On my pathology report, what does 'necrotizing granulomatous inflammation' specifically mean for my long-term lung health?

Questions for You

  • • Am I keeping copies of my pathology and lab reports so I can compare them over time?
  • • Do I understand that even if my ANCA blood test is negative, the disease can still be active?
  • • Have I noticed any small changes in my health (like new skin spots or eye redness) that I should report for my next BVAS assessment?
  • • How comfortable do I feel asking my doctor to explain a term on my lab report that I don't understand?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    ANCA-negative Pauci-immune Vasculitis, an Often-missed Clinical Entity: A Case Report.

    Tudu A, Paul S, Ghosh UC, Banerjee B

    The Journal of the Association of Physicians of India 2025; (73(11S)):40-42 doi:10.59556/japi.73.1245.

    PMID: 41296302
  2. 2

    [How do I treat ANCA vasculitis with renal involvement].

    Crucil M, Regnier C, Von Frenckell C, et al.

    Revue medicale de Liege 2025; (80(9)):556-562.

    PMID: 40931730
  3. 3

    [Granulomatosis with polyangiitis and microscopic polyangiitis].

    Klapa S, Arnold S, Lamprecht P

    Laryngo- rhino- otologie 2024; (103(7)):490-499 doi:10.1055/a-2217-4457.

    PMID: 38211619
  4. 4

    Granulomatosis with Polyangiitis: Recurrence or Treatment Consequences?

    Diegues A, Tavares J, Sá D, et al.

    European journal of case reports in internal medicine 2021; (8(4)):002448 doi:10.12890/2021_002448.

    PMID: 33987124
  5. 5

    Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.

    Wójcik K, Masiak A, Jeleniewicz R, et al.

    Polish archives of internal medicine 2022; (132(3)) doi:10.20452/pamw.16187.

    PMID: 34985235
  6. 6

    Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis.

    Konstantouli AM, Lioulios G, Stai S, et al.

    Life (Basel, Switzerland) 2022; (12(10)) doi:10.3390/life12101467.

    PMID: 36294902
  7. 7

    A Rare Case of Granulomatosis With Polyangiitis Complicated by Splenic Rupture.

    Awad OM, Srour IA, Mekdad FA, et al.

    Cureus 2024; (16(1)):e52536 doi:10.7759/cureus.52536.

    PMID: 38371079
  8. 8

    ANCA associated vasculitis (AAV): a review for internists.

    Yaseen K, Mandell BF

    Postgraduate medicine 2023; (135(sup1)):3-13 doi:10.1080/00325481.2022.2102368.

    PMID: 35831990
  9. 9

    Antineutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis localized to the lungs.

    Ohteru Y, Hamada K, Oishi K, et al.

    Respiratory medicine case reports 2022; (36()):101600 doi:10.1016/j.rmcr.2022.101600.

    PMID: 35169540
  10. 10

    [Granulomatous vasculitides and vasculitides with extravascular granulomatosis].

    Arnold S, Klapa S, Holl-Ulrich K, et al.

    Zeitschrift fur Rheumatologie 2022; (81(7)):558-566 doi:10.1007/s00393-022-01249-7.

    PMID: 35962194
  11. 11

    Granulomatous Inflammation in ANCA-Associated Vasculitis.

    Müller A, Krause B, Kerstein-Stähle A, et al.

    International journal of molecular sciences 2021; (22(12)) doi:10.3390/ijms22126474.

    PMID: 34204207
  12. 12

    Diagnosis and management of ANCA-associated vasculitis.

    Kronbichler A, Bajema IM, Bruchfeld A, et al.

    Lancet (London, England) 2024; (403(10427)):683-698 doi:10.1016/S0140-6736(23)01736-1.

    PMID: 38368016
  13. 13

    A Rare Case of Nephrotic-Range Proteinuria in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.

    Nasr R, Balasubramanian P, Desiderio L, Abdelattif M

    Cureus 2022; (14(5)):e24889 doi:10.7759/cureus.24889.

    PMID: 35572457
  14. 14

    Overview of the Pathogenesis of ANCA-Associated Vasculitis.

    Xiao H, Hu P, Falk RJ, Jennette JC

    Kidney diseases (Basel, Switzerland) 2016; (1(4)):205-15 doi:10.1159/000442323.

    PMID: 27536680
  15. 15

    Monitoring the activity of anca-associated vasculitis: some questionnaires and laboratory parameters

    Suszek D, Majdan M, Widłak K, et al.

    Wiadomosci lekarskie (Warsaw, Poland : 1960) 2019; (72(10)):2010-2016.

    PMID: 31983066
  16. 16

    Measuring Vasculitis with Numbers: Outcome Scores.

    Batu ED, Ozen S

    Current rheumatology reviews 2020; (16(1)):21-28 doi:10.2174/1573397115666191126093927.

    PMID: 31804163
  17. 17

    Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis.

    Ahn SS, Yoon T, Song JJ, et al.

    In vivo (Athens, Greece) 2021; (35(3)):1761-1768 doi:10.21873/invivo.12435.

    PMID: 33910860
  18. 18

    Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis.

    Tsuboi K, Noguchi K, Kitano M, et al.

    Immunological medicine 2022; (45(4)):238-243 doi:10.1080/25785826.2022.2094592.

    PMID: 35802795
  19. 19

    Consideration of Therapeutic Plasma Exchange in Association With Inflammatory Lesions in ANCA-Associated Glomerulonephritis: A Real-World Retrospective Study From a Single Center.

    Tampe D, Ströbel P, Korsten P, et al.

    Frontiers in immunology 2021; (12()):645483 doi:10.3389/fimmu.2021.645483.

    PMID: 34220805
  20. 20

    Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Causes Aortic Valve Degeneration and Severe Aortic Regurgitation.

    Guterbaum TJ, Husic M, Voss A, Dahl JS

    The American journal of case reports 2019; (20()):423-429 doi:10.12659/AJCR.912693.

    PMID: 30930460

This page explains Granulomatosis with polyangiitis (GPA) pathology terminology for educational purposes only. Your doctor and pathologist are the best sources for interpreting your specific test results.

Stay up to date

Get notified when new research about Granulomatosis with polyangiitis is published.

No spam. Unsubscribe anytime.